Currently, out of the existing stock ratings of Terence Flynn - 103 which are a Hold (40.55%), 28 which are a Sell (11.02%), 123 which are a Buy (48.43%)

Terence Flynn

Work Performance Price Targets & Ratings Chart

Analyst Terence Flynn works at MORGAN STANLEY and is covering the Healthcare sector with 527 price targets and ratings displayed on 34 stocks. Previously, Terence Flynn worked at GOLDMAN SACHS.

Terence Flynn's average stock forecast success ratio is 61.05% with an average time for price targets to be met of 180.85 days.

Most recent stock forecast was given on ARVN, Arvinas at 13-Nov-2023.

Wall Street Analyst Terence Flynn

Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for ARVN (ARVINAS) at 11/13/2023. The price target of $20 was fulfilled within 2 days with a profit of $5.01 (33.42%) receiving and performance score of 167.11.

Average potential price target upside

of $129.67 (27.55%) on REGN (REGENERON PHARMACEUTICALS).
of $77.43 (26.1%) on LLY (ELI LILLY AND COMPANY).
of $59.6 (48.4%) on AMGN (AMGEN).

ALKS Alkermes plc ALNY Alnylam Pharmaceuticals ALXN AMGN Amgen ARVN Arvinas BIIB Biogen BPMC Blueprint Medicines CELG FGEN FibroGen GILD Gilead Sciences LLY Eli Lilly and Company MRK Merck . OGN PFE Pfizer REGN Regeneron Pharmaceuticals RVNC Revance Therapeutics TBIO AGIO Agios Pharmaceuticals VRTX Vertex Pharmaceuticals ABBV AbbVie BMY BristolMyers Squibb Company CLVS Clovis Oncology JNJ Johnson & Johnson RPRX UTHR United Therapeutics XLRN Acceleron Pharma NTLA Intellia Therapeutics AGN CCCC C4 Therapeutics CRSP CRISPR Therapeutics AG CTMX CytomX Therapeutics ITMN MGTA Magenta Therapeutics RCUS Arcus Biosciences

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Jessica Fye (JPMORGAN)